Why Choose Guires's FRL as Your Food Product Development (FPD) Consultant and Partner?

There are several options in almost every product area in today’s market, and the difficulty is in coming up with unique items that stand out and connect with customers. Guires Food Research Lab (FRL) takes a holistic approach to creating food and beverage products. We define, demographically target, and build effective goods through a sequential process for category selection and comprehension. The client can visit the lab to learn the process. We offer unlimited rounds of revisions to ensure customer satisfaction. The final product prototype, along with the documentation process, including the video (through email), will be shipped to the client, and in case the client is not satisfied with the video, a food technology consultant will visit the place for the product demo at the client’s costs.

What are the different forms that you deliver the Food Product Formulations?

The food industry is witnessing a new form of consumption. Keeping that in mind, we can formulate the products in the form of ready-to-eat, ready-to-drink, ready-to-mix, ready-to-serve, and ready-to-cook food products. We use ingredients that offer an added value to the development and improve its indulgence and sustainability in terms of its functional ingredients, plant-based food dyes, and natural preservatives with a clean label.

What are the sectors Food Research Lab cover?

We cover a wide range of sectors such as soups, sauces and dips, chips, tortillas, dry beverage powder, plant-based products, masalas, puddings, instant mixes and many more.

How is sensory testing been carried out?

Our sensory examination leads to the precise formulation and recipe recommendations. We develop data-driven design models based on sensory research and customer insights. The fact-based design methodology used by Guires reduces risk and gives our clients market confidence while cutting development time in half. With our dedicated sensory lab facility, our team takes satisfaction in creating and optimizing successful products in the marketplace, generating a favourable return on investment, and developing brand advocates.

Understanding Inflammatory Bowel Disease

20 Apr

Inflammatory Bowel Disease

by admin

in What Science Can Do

Comments

Epithelial cells, stroma, immune cells, and goblet and Paneth cells make up the intestinal mucosa. The intestinal epithelium consists of an epithelial monolayer sandwiched between immune cells and tightly linked by tight junctions. The intestine is made up of many projections called villi and invasions known as Lieberkühn crypts. In addition to aiding in the absorption of nutrients, the epithelium acts as a physical barrier between the intestinal lumen’s contents. Additionally, the epithelium transmits and receives signals to and from the immune system and the gut bacteria. ⁴

The epithelium contains goblet and Paneth cells, which inhibit the spread of luminal pathogens by producing mucus and antimicrobial peptides, respectively. In Crohn’s disease, a significant decrease in goblet cell counts has been associated with a loss of mucus layer thickness, and aberrant mucus composition has been observed in ulcerative colitis. ⁵

Ulcerative colitis (UC) and Crohn’s disease (CD) are two chronic inflammatory disease entities that are included under the umbrella term of inflammatory bowel disease (IBD). Essentially, endoscopic, radiological, histological, and classical symptomatology form the basis of the diagnosis. ¹

Based on clinical features, disease location, and histological traits, IBD is categorized as either ulcerative colitis (UC) or Crohn’s disease (CD).

In the colon, UC results in chronic inflammation and superficial ulcerative disease, while CD is a transmural illness that can affect any portion of the gastrointestinal tract and is frequently linked to the production of granulomas.

IBD significantly burdens the nation’s healthcare system since both UC and CD necessitate ongoing care and surveillance. ²

Live bacteria known as probiotics are intended to cure human immunodeficiency virus-induced diarrhea, difficile colitis relapses, and traveler’s diarrhea. Prebiotics are also necessary substrates for elevated growth of probiotics. Probiotics may change the makeup of the intestines after consumption by preventing the expansion of potentially harmful bacteria, which is advantageous to human health. ⁸Probiotic therapy has been shown to be helpful for IBD patients in a number of animal models. Additionally, investigations with Saccharomyces boulardii, VSL#3, and Escherichia coli Nissle 1917 (EcN 1917) ⁷have been undertaken on patients, and it has been suggested that these yeasts may be effective in the treatment of IBD. ⁶